Skip to main content Accessibility help
×
Home

Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

  • Sergiy Konovalov (a1), Sunanda Muralee (a1) and Rajesh R. Tampi (a1)

Abstract

Objective: To review and summarize the currently available data on the use of anticonvulsant mood stabilizers (carbamazepine, valproic acid, gabapentin, lamotrigine, topiramate) in the treatment of behavioral and psychological symptoms of dementia (BPSD); to determine whether these medications can be recommended for routine clinical use.

Methods: Literature search in five databases (PubMed, MEDLINE, EMBASE, PsychINFO and COCHRANE collaboration) and analysis of the randomized controlled double-blinded clinical trials found therein.

Results: A total of seven RCTs were identified (two for carbamazepine and five for valproate). One study showed statistically significant improvement of BPSD in the medication group in comparison to the placebo group; five studies showed no significant differences; one study showed statistically significant worsening of the symptoms in the medication group vs. placebo. The majority of the studies reported significantly more frequent adverse effects in the medication group.

Conclusion: Although clearly beneficial in some patients, anticonvulsant mood stabilizers cannot be recommended for routine use in the treatment of BPSD at the present time.

Copyright

Corresponding author

Correspondence should be addressed to: Dr. Rajesh R. Tampi, Director, Geriatric Psychiatry Fellowship Program, Yale University School of Medicine, LV-121 Yale New Haven Psychiatric Hospital, 184 Liberty Street, New Haven, CT 06519, U.S.A. Phone: +1 203 688 9893; Fax: +1 203 688 9709. Email: rajesh.tampi@yale.edu.

References

Hide All
Alkhalil, C., Tanvir, F., Alkhalil, B. and Lowenthal, D. T. 2004. Treatment of sexual disinhibition in dementia: case reports and review of the literature. American Journal of Therapeutics, 11, 231235.
Aulakh, J. S., Hawkins, J. W., Athwal, H. S., Sheikh, J. I., Yesavage, J. and Tinklenberg, J. R. 2005. Tolerability and effectiveness of lamotrigine in complex elderly patients. Journal of Geriatric Psychiatry and Neurology, 18, 811.
Buchalter, E. N. and Lantz, M. S. 2001. Treatment of impulsivity and aggression in a patient with vascular dementia. Geriatrics, 56, 5354.
Chambers, C. Bain, J. and Rosbottom, R. 1982. Carbamazepine in senile dementia and overactivity: a placebo controlled double blind trial. IRCS Medical Science, 10, 505506.
Chengappa, K. N. et al. 1999. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disorders, 1, 4253.
Coen, R. F., Swanwick, G. R., O'Boyle, C. A. and Coakley, D. 1997. Behaviour disturbance and other predictors of carer burden in Alzheimer's disease. International Journal of Geriatric Psychiatry, 12, 331336.
Cohen, D. et al. 1993. Psychopathology associated with Alzheimer's disease and related disorders. Journal of Gerontology, 48, M255260.
Cooney, C. Mortimer, A., Smith, A., Newton, K. and Wrigley, M. 1996. Carbamazepine use in aggressive behavior associated with senile dementia. International Journal of Geriatric Psychiatry, 11, 901905.
Cummings, J. L. and Back, C. 1998. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. American Journal of Geriatric Psychiatry, 6, S6478.
De Leon, O. A. 2004. Treatment of psychotic symptoms with lamotrigine in Alzheimer's disease. Journal of Clinical Psychopharmacology, 24, 232233.
Fhager, B., Meiri, I. M., Sjogren, M. and Edman, A. 2003. Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study. International Psychogeriatrics, 15, 307309.
Fitton, A. and Goa, K. L. 1995. Lamotrigine. an update of its pharmacology and therapeutic use in epilepsy. Drugs, 50, 691713.
Freymann, N., Michael, R., Dodel, R. and Jessen, F. 2005. Successful treatment of sexual disinhibition in dementia with carbamazepine – a case report. Pharmacopsychiatry, 38, 144145.
Gleason, R. P. and Schneider, L. S. 1990. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. Journal of Clinical Psychiatry, 51, 115118.
Goldberg, R. J. 1999. The use of adjunctive divalproex for neuroleptic unresponsive behavioral disturbances in nursing home residents with dementia. Annals of Long Term Care, 7, 6366.
Hawkins, J. W., Tinklenberg, J. R., Sheikh, J. I., Peyser, C. E. and Yesavage, J. A. 2000. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. American Journal of Geriatric Psychiatry, 8, 221225.
Herrmann, N. 1998. Valproic acid treatment of agitation in dementia. Canadian Journal of Psychiatry/Revue Canadienne de Psychiatrie, 43, 6972.
Herrmann, N., Lanctot, K. and Myszak, M. 2000. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia. Journal of Clinical Psychopharmacology, 20, 9093.
Herrmann, N., Lanctot, K. L., Rothenburg, L. S. and Eryavec, G. 2007. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 23, 116119.
Holmes, C. et al. 2001. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. Journal of Neurology, Neurosurgery and Psychiatry, 71, 777779.
Jost, B. C. and Grossberg, G. T. 1996. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. Journal of the American Geriatrics Society, 44, 10781081.
Kasckow, J. W., McElroy, S. L., Cameron, R. L., Mahler, L. L. and Fudala, S. J. 1997. A pilot study on the use of divalproex sodium in the treatment of behavioral agitation in elderly patients with dementia: assessment with the BEHAVE-AD and CGI rating scales. Current Therapeutic Research, Clinical and Experimental, 58, 981989.
Kozman, M. N., Wattis, J. and Curran, S. 2006. Pharmacological management of behavioural and psychological disturbance in dementia. Human Psychopharmacology, 21, 112.
Lanari, A., Amenta, F., Silvestrelli, G., Tomassoni, D. and Parnetti, L. 2006. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mechanisms of Ageing and Development, 127, 158165.
Lawlor, B. 2002. Managing behavioural and psychological symptoms in dementia. British Journal of Psychiatry, 181, 463465.
Lemke, M. R. 1995. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics. Journal of Clinical Psychiatry, 56, 354357.
Lyketsos, C. G., Steele, C., Baker, L., Galik, E., Kopunek, S., Steinberg, M. and Warren, A. 1997. Major and minor depression in Alzheimer's disease: prevalence and impact. Journal of Neuropsychiatry and Clinical Neuroscience, 9, 556561.
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C. and Breitner, J. C. 2000. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. American Journal of Psychiatry, 157, 708714.
Marin, D. B. and Greenwald, B. S. 1989. Carbamazepine for aggressive agitation in demented patients during nursing care. American Journal of Psychiatry, 146, 805.
Meinhold, J. M., Blake, L.M., Mini, L. J., Welge, J. A., Schwiers, M. and Hughes, A. 2005. Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia. Drugs & Aging, 22, 615626.
Mendez, M. and Lim, G. 2003. Seizures in elderly patients with dementia: epidemiology and management. Drugs & Aging, 20, 791803.
Miller, L. J. 2001. Gabapentin for treatment of behavioral and psychological symptoms of dementia. Annals of Pharmacotherapy, 35, 427431.
Moretti, R., Torre, P., Antonello, R. M., Cazzato, G. and Bava, A. 2003. Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation. Drugs & Aging, 20, 10351040.
Murman, D. L., Chen, Q., Powell, M. C., Kuo, S.B., Bradley, C. J. and Colenda, C. C. 2002. The incremental direct costs associated with behavioral symptoms in AD. Neurology, 59, 17211729.
Nakajima, Y., Suzuki, K., Tochigi, A., Nitta, I., Tsuchiya, K. and Koyama, T. 2002. Effect of sodium valproate on behavioral disturbances in three patients with vascular dementia. Seishin Igaku (Clinical Psychiatry), 44, 761763.
Narayan, M. and Nelson, J. C. 1997. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic. Journal of Clinical Psychiatry, 58, 351354.
Olin, J. T., Fox, L. S., Pawluczyk, S., Taggart, N. A. and Schneider, L. S. 2001. A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with alzheimer disease. American Journal of Geriatric Psychiatry, 9, 400405.
Patterson, J. F. 1988. A preliminary study of carbamazepine in the treatment of assaultive patients with dementia. Journal of Geriatric Psychiatry and Neurology, 1, 2123.
Porsteinsson, A. P., Tariot, P. N., Erb, R. and Gaile, S. 1997. An open trial of valproate for agitation in geriatric neuropsychiatric disorders. American Journal of Geriatric Psychiatry, 5, 344351.
Porsteinsson, A. P. et al. 2001. Placebo-controlled study of divalproex sodium for agitation in dementia. American Journal of Geriatric Psychiatry, 9, 5866.
Porsteinsson, A. P. et al. 2003. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial. American Journal of Geriatric Psychiatry, 11, 434440.
Raudino, F., Mascalzi, M. G. and Zagami, A. 2004. Gabapentin and behavioral disorders in severe Alzheimer disease. Journal of Clinical Psychopharmacology, 24, 459460.
Regan, W. M. and Gordon, S. M. 1997. Gabapentin for behavioral agitation in Alzheimer's disease. Journal of Clinical Psychopharmacology, 17, 5960.
Roane, D. M., Feinberg, T. E., Meckler, L., Miner, C. R., Scicutella, A. and Rosenthal, R. N. 2000. Treatment of dementia-associated agitation with gabapentin. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 4043.
Robert, P. 2002. Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine. Current Medical Research Opinion, 18, 156171.
Rossi, P., Serrao, M. and Pozzessere, G. 2002. Gabapentin-induced worsening of neuropsychiatric symptoms in dementia with Lewy bodies: case reports. European Neurology, 47, 5657.
Sandborn, W. D., Bendfeldt, F. and Hamdy, R. 1995. Valproic acid for physically aggressive behavior in geriatric patients. American Journal of Geriatric Psychiatry, 3, 239242.
Sheldon, L. J., Ancill, R. J. and Holliday, S. G. 1998. Gabapentin in geriatric psychiatry patients. Canadian Journal of Psychiatry, 43, 422423.
Sink, K. M., Holden, K. F. and Yaffe, K. 2005. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA, 293, 596608.
Sival, R. C., Haffmans, P. M. J., van Gent, P. P. and van Nieuwkerk, J. F. 1994. The effects of sodium valproate on disturbed behavior in dementia. Journal of the American Geriatrics Society, 42, 906907.
Sival, R. C., Haffmans, P. M., Jansen, P. A., Duursma, S. A. and Eikelenboom, P. 2002. Sodium valproate in the treatment of aggressive behavior in patients with dementia–a randomized placebo controlled clinical trial. International Journal of Geriatric Psychiatry, 17, 579585.
Sival, R. C., Duivenvoorden, H. J., Jansen, P. A. F., Haffmans, J., Duursma, S. A. and Eikelenboom, P. 2004. Sodium valproate in aggressive behaviour in dementia: a twelve-week open label follow-up study. International Journal of Geriatric Psychiatry, 19, 305312.
Steele, C., Rovner, B., Chase, G. A. and Folstein, M. 1990. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. American Journal of Psychiatry, 147, 10491051.
Stern, Y. et al. 1994. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the predictors study. Neurology, 44, 23002307.
Stern, Y., Mayeux, R., Sano, M., Hauser, W. A. and Bush, T. 1987. Predictors of disease course in patients with probable Alzheimer's disease. Neurology, 37, 16491653.
Takahashi, M. and Akagi, M. 1996. Case report of sodium valproate treatment of aggression associated with Alzheimer's disease. Noto Shinkei (Brain & Nerve), 48, 757760.
Tariot, P. N. 2003. Valproate use in neuropsychiatric disorders in the elderly. Psychopharmacology Bulletin, 37, 116128.
Tariot, P. N. et al. 1998. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. American Journal of Psychiatry, 155, 5461.
Tariot, P. N. et al. 2001. Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial. Current Therapeutic Research – Clinical and Experimental, 62, 5167.
Tariot, P., Porsteinsson, A. P., Jakimovich, L. J., Kowalski, N. and Holt, C. 2002. Open valproate treatment following a double-blind trial for agitation. Proceedings of the 8th International Conference on Alzheimer's Disease and Related Disorders, 20–25 July, Stockholm, Sweden. Abstract No. 440.
Tariot, P. N. et al. . and Alzheimer's Disease Cooperative Study 2005. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial. American Journal of Geriatric Psychiatry, 13, 942949.
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A. and Wolf, H. H. 2000. Topiramate modulates gaba-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia, 41 (Suppl. 1), S17S20.

Keywords

Related content

Powered by UNSILO

Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

  • Sergiy Konovalov (a1), Sunanda Muralee (a1) and Rajesh R. Tampi (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.